EDAP TMS S.A. (EDAP)

Market Cap	51.60M
Revenue (ttm)	66.38M
Net Income (ttm)	-19.69M
Shares Out	37.39M
EPS (ttm)	-0.53
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,425
Open	1.360
Previous Close	1.310
Day's Range	1.360 - 1.380
52-Week Range	1.260 - 7.730
Beta	0.12
Analysts	Buy
Price Target	8.50 (+515.94%)
Earnings Date	May 15, 2025

About EDAP

EDAP TMS S.A., together with its subsidiaries, develops, produces, markets, distributes, and maintains a portfolio of minimally invasive medical devices for the treatment of urological diseases in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution Services (DIST) segments. The HIFU segment develops, manufactures, and markets medical devices based on HIFU technology for the minimally invasive treatment of urolog...

• Industry: Medical Distribution
• Sector: Healthcare
• IPO Date: Jul 31, 1997
• Employees: 310
• Stock Exchange: NASDAQ
• Ticker Symbol: EDAP
• Website: https://focalone.com

Financial Performance

In 2024, EDAP TMS's revenue was 64.12 million, an increase of 6.11% compared to the previous year's 60.42 million. Losses were -19.02 million, -10.20% less than in 2023.

Financial numbers in EUR

Analyst Forecast

According to 3 analysts, the average rating for EDAP stock is "Buy." The 12-month stock price forecast is $8.5, which is an increase of 515.94% from the latest price.

Price Target

$8.5

(515.94% upside)

Analyst Consensus: Buy